Solulink Overview
- Year Founded
-
2000
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
Solulink General Information
Description
Operator of an innovative technology platform intended to offer products to link biomolecules together. The company's innovative technology platform offers reagents, conjugation kits and conjugation services used for the proprietary conjunction of bio-molecules to each other or to a solid surface, enabling clients to avail premium products.
Contact Information
Website
www.solulink.comCorporate Office
- 9853 Pacific Heights Boulevard
- Suite H
- San Diego, CA 92121
- United States
Corporate Office
- 9853 Pacific Heights Boulevard
- Suite H
- San Diego, CA 92121
- United States
Solulink Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Merger/Acquisition | 01-Feb-2017 | Completed | Generating Revenue | |||
| 8. Later Stage VC | 02-Dec-2013 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 17-Jul-2013 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 21-Nov-2011 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 28-Feb-2011 | Completed | Generating Revenue | |||
| 4. Grant | 15-Nov-2010 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 28-Jan-2010 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 28-Feb-2008 | $830K | $1.16M | Completed | Generating Revenue | |
| 1. Angel (individual) | 30-Jun-2006 | $325K | $325K | Completed | Generating Revenue |
Solulink Patents
Solulink Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2013177046-A1 | Methods and/or use of oligonucleotide conjugates for suppressing background due to cross-hybridization | Inactive | 21-May-2012 | ||
| US-20130035259-A1 | Methods and/or systems producing and providing sets of oligonucleotide conjugates for assays and detections | Inactive | 22-Nov-2010 | ||
| EP-2643480-A2 | Methods and/or use of oligonucleotide conjugates for assays and detections | Inactive | 22-Nov-2010 | ||
| WO-2012071428-A2 | Methods and/or use of oligonucleotide conjugates for assays and detections | Inactive | 22-Nov-2010 | ||
| WO-2012071428-A3 | Methods and/or use of oligonucleotide conjugates for assays and detections | Inactive | 22-Nov-2010 | C12Q1/6804 |
Solulink Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| KHK Ventures | Venture Capital | Minority | ||
| National Cancer Institute | Government | |||
| National Institute Of Allergy and Infectious Diseases | Government | |||
| TCA Venture Group | Angel Group | Minority |
Solulink FAQs
-
When was Solulink founded?
Solulink was founded in 2000.
-
Where is Solulink headquartered?
Solulink is headquartered in San Diego, CA.
-
What industry is Solulink in?
Solulink’s primary industry is Biotechnology.
-
Is Solulink a private or public company?
Solulink is a Private company.
-
What is Solulink’s current revenue?
The current revenue for Solulink is .
-
How much funding has Solulink raised over time?
Solulink has raised $4.49M.
-
Who are Solulink’s investors?
KHK Ventures, National Cancer Institute, National Institute Of Allergy and Infectious Diseases, and TCA Venture Group have invested in Solulink.
-
When was Solulink acquired?
Solulink was acquired on 01-Feb-2017.
-
Who acquired Solulink?
Solulink was acquired by TriLink BioTechnologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
